Daunorubicin
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Oncology & Critical Care treatment.
🧴 Clinical Application
Administer by rapid intravenous infusion into a freely running IV line over 30 to 45 minutes. Exercise extreme caution to prevent extravasation. Cumulative lifetime dose must not exceed 550 mg/m² (or 400 mg/m² if prior chest radiation).
⚠️ Side Effects
Common: Bone marrow suppression (profound neutropenia, thrombocytopenia), red-colored urine, alopecia, nausea, mucositis. Rare/Severe: Dose-dependent cardiomyopathy, extravasation tissue necrosis, and secondary leukemias.
🛡️ Safety Warnings
Black Box Warning: Severe cardiotoxicity and extravasation necrosis. Vesicant agent. Evaluate cardiac ejection fraction prior to treatment. Contraindicated in pre-existing severe myocardial insufficiency or severe bone marrow depression.
Jan Aushadhi Products containing Daunorubicin
Found 1 generic formulation(s) containing this active ingredient.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Daunorubicin.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Daunorubicin Hydrochloride Injection 20mg | vial | ₹204.00 | Daunotec, DAUNOMAC | ₹165.72 | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Daunorubicin generics.